Back to School: How biopharma can reboot drug development. Access exclusive analysis here
NXTR and Becton, Dickinson redefined the terms of their May 1993 agreement to develop in vitro diagnostic reagents using NXTR's SELEX
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury